Literature DB >> 10371187

Anaphylaxis after rechallenge with abacavir.

R P Walensky, J H Goldberg, J P Daily.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10371187     DOI: 10.1097/00002030-199905280-00022

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  8 in total

Review 1.  Antiretroviral therapy: current drugs.

Authors:  Alice K Pau; Jomy M George
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

Review 2.  Management of patients with HIV in the intensive care unit.

Authors:  Henry Masur
Journal:  Proc Am Thorac Soc       Date:  2006

Review 3.  Abacavir: a review of its clinical potential in patients with HIV infection.

Authors:  P S Hervey; C M Perry
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

4.  Abacavir/lamivudine combination in the treatment of HIV: a review.

Authors:  Geetha Sivasubramanian; Emmanuel Frempong-Manso; Rodger D Macarthur
Journal:  Ther Clin Risk Manag       Date:  2010-03-03       Impact factor: 2.423

5.  Abacavir-induced fulminant hepatic failure in a HIV/HCV co-infected patient.

Authors:  Christopher Haas; Mary Rodriguez Ziccardi; Jody Borgman
Journal:  BMJ Case Rep       Date:  2015-12-15

Review 6.  Abacavir pharmacogenetics--from initial reports to standard of care.

Authors:  Michael A Martin; Deanna L Kroetz
Journal:  Pharmacotherapy       Date:  2013-05-03       Impact factor: 4.705

7.  HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.

Authors:  Manuela G Neuman; Michelle Schneider; Radu M Nanau; Charles Parry
Journal:  Int J Hepatol       Date:  2012-03-11

8.  Antiretroviral Therapy-associated Serious and Life-threatening Toxicities.

Authors:  Alice K. Pau
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.663

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.